MEDICLIN
Market Cap
€188.1m
Last Updated
2020/07/01 21:08 UTC
Data Sources
Company Financials +
Executive Summary
MEDICLIN Aktiengesellschaft operates hospitals in Germany.
Rewards
Risk Analysis
Snowflake Analysis
Good value with moderate growth potential.
Share Price & News
How has MEDICLIN's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
1.5%
MED
1.3%
DE Healthcare
1.5%
DE Market
1 Year Return
-20.5%
MED
-1.2%
DE Healthcare
-1.8%
DE Market
Return vs Industry: MED underperformed the German Healthcare industry which returned -1.7% over the past year.
Return vs Market: MED underperformed the German Market which returned -0.7% over the past year.
Shareholder returns
| MED | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.5% | 1.3% | 1.5% |
| 30 Day | -2.5% | 2.3% | 4.3% |
| 90 Day | -7.0% | 26.2% | 25.1% |
| 1 Year | -20.5%-20.5% | -0.9%-1.2% | 0.2%-1.8% |
| 3 Year | -32.2%-33.3% | -24.3%-26.7% | 1.3%-6.9% |
| 5 Year | 15.1%13.1% | -8.1%-12.3% | 15.0%-0.2% |
Price Volatility Vs. Market
How volatile is MEDICLIN's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
We're Not So Sure You Should Rely on MEDICLIN's (ETR:MED) Statutory Earnings1 month ago | Simply Wall St
Shareholders Should Look Hard At MEDICLIN Aktiengesellschaft’s (ETR:MED) 0.6%Return On Capital1 month ago | Simply Wall St
Is MEDICLIN (ETR:MED) Using Too Much Debt?Valuation
Is MEDICLIN undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MED (€3.96) is trading below our estimate of fair value (€47.82)
Significantly Below Fair Value: MED is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MED is poor value based on its PE Ratio (34.5x) compared to the Healthcare industry average (21.3x).
PE vs Market: MED is poor value based on its PE Ratio (34.5x) compared to the German market (20.7x).
Price to Earnings Growth Ratio
PEG Ratio: MED is good value based on its PEG Ratio (0.7x)
Price to Book Ratio
PB vs Industry: MED is good value based on its PB Ratio (1x) compared to the DE Healthcare industry average (1.4x).
Next Steps
Future Growth
How is MEDICLIN forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
49.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MED's forecast earnings growth (49.2% per year) is above the savings rate (0.2%).
Earnings vs Market: MED's earnings (49.2% per year) are forecast to grow faster than the German market (22.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MED's revenue (4.2% per year) is forecast to grow slower than the German market (5.8% per year).
High Growth Revenue: MED's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MED's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has MEDICLIN performed over the past 5 years?
-24.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MED has a large one-off gain of €9.6M impacting its March 31 2010 financial results.
Growing Profit Margin: MED's current net profit margins (0.8%) are lower than last year (1%).
Past Earnings Growth Analysis
Earnings Trend: MED's earnings have declined by -24.8% per year over the past 5 years.
Accelerating Growth: MED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MED had negative earnings growth (-16.8%) over the past year, making it difficult to compare to the Healthcare industry average (9.7%).
Return on Equity
High ROE: MED's Return on Equity (2.9%) is considered low.
Next Steps
Financial Health
How is MEDICLIN's financial position?
Financial Position Analysis
Short Term Liabilities: MED's short term assets (€163.7M) exceed its short term liabilities (€152.1M).
Long Term Liabilities: MED's short term assets (€163.7M) do not cover its long term liabilities (€553.4M).
Debt to Equity History and Analysis
Debt Level: MED's debt to equity ratio (53%) is considered high.
Reducing Debt: MED's debt to equity ratio has increased from 34.6% to 53% over the past 5 years.
Debt Coverage: MED's debt is well covered by operating cash flow (73%).
Interest Coverage: MED's interest payments on its debt are not well covered by EBIT (0.5x coverage).
Balance Sheet
Next Steps
Dividend
What is MEDICLIN current dividend yield, its reliability and sustainability?
1.26%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MED's dividend (1.26%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.28%).
High Dividend: MED's dividend (1.26%) is low compared to the top 25% of dividend payers in the German market (3.82%).
Stability and Growth of Payments
Stable Dividend: MED's dividend payments have been volatile in the past 10 years.
Growing Dividend: MED's dividend payments have not increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (43.5%), MED's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MED's dividends in 3 years are forecast to be well covered by earnings (18.2% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.5yrs
Average management tenure
CEO
Volker Hippler (50yo)
4.25yrs
Tenure
Mr. Volker Hippler has been Chairman of Management Board at MEDICLIN Aktiengesellschaft since April 1, 2016 and has been its CEO since April 2016. Mr. Hippler worked in a consulting company focussing on he ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Management Board & CEO | 4.25yrs | no data | no data | |
| CFO & Member of the Management Board | 1.83yrs | no data | no data | |
| Head of Group Accounting | no data | no data | no data | |
| Head of Internal Audit | 0.50yr | no data | no data | |
| Head of Law | 0.50yr | no data | no data | |
| Head of Corporate Communications & Press Spokeswoman | 0.50yr | no data | no data | |
| Head of Purchasing & Medical Technology | 0.50yr | no data | no data | |
| Head of Payroll & Application Management | 0.50yr | no data | no data | |
| Head of Finance & Accounting | 0.50yr | no data | no data | |
| Head of Group Controlling | 0.50yr | no data | no data |
0.5yrs
Average Tenure
Experienced Management: MED's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Advisory Board | no data | no data | no data | |
| Deputy Chairman of Supervisory Board | 18.17yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of the Supervisory Board | 15.17yrs | €14.25k | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Employee Representative Member of Supervisory Board | 7.83yrs | €12.26k | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Employee Representative Member of Supervisory Board | 7.83yrs | €12.00k | no data | |
| Chairman of the Supervisory Board | 0.67yr | no data | no data |
7.8yrs
Average Tenure
Experienced Board: MED's board of directors are considered experienced (7.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
MEDICLIN Aktiengesellschaft's company bio, employee growth, exchange listings and data sources
Key Information
- Name: MEDICLIN Aktiengesellschaft
- Ticker: MED
- Exchange: XTRA
- Founded:
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €188.100m
- Shares outstanding: 47.50m
- Website: https://www.mediclin.de
Number of Employees
Location
- MEDICLIN Aktiengesellschaft
- Okenstrasse 27
- Offenburg
- Baden-Württemberg
- 77652
- Germany
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MED | DB (Deutsche Boerse AG) | Yes | Bearer Shares | DE | EUR | Dec 2000 |
| MED | XTRA (XETRA Trading Platform) | Yes | Bearer Shares | DE | EUR | Dec 2000 |
| 0NDG | LSE (London Stock Exchange) | Yes | Bearer Shares | GB | EUR | Dec 2000 |
Biography
MEDICLIN Aktiengesellschaft operates hospitals in Germany. It operates through Post-Acute, Acute, and Other Activities segments. The Post-Acute segment offers services in the fields of subsequent nursing and curative treatments. This segment’s subsequent nursing treatment includes various medical measures required to facilitate the healing process and return the patient to a functioning state after acute care treatment; and curative treatment comprises prophylactic measures against the occurrence or reoccurrence of illnesses. The Acute segment provides medical services focusing on neurology and neurological early rehabilitation, as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. This segment also offers services in the areas of cardiology, oncology, and ENT, as well as acute outpatient services. The Other Activities segment offers full-time and short-term nursing care; and outpatient nursing care services. As of December 31, 2018, the company operated 36 clinics, 7 nursing care facilities, 3 home nursing care services, and 9 medical care centers with a total capacity of approximately 8,300 beds in 11 German federal states. MEDICLIN Aktiengesellschaft is headquartered in Offenburg, Germany.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/07/01 21:08 |
| End of Day Share Price | 2020/07/01 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.